Eyebright 430 mg Ingredients & Drug Interactions
by Bronson Laboratories
What is this page for?
First and foremost: checking Eyebright 430 mg against your medications. The heart of this page is the interaction checker and the full interaction report — how this product’s ingredients may interact with prescription and over-the-counter medicines you may be taking.
Around that, we add a pharmacist’s high-level view of the product as a whole — what’s inside, the evidence for its stated use, how transparent the label is, and what safety data exists — so you can see the full picture in one place. It’s educational information from our licensed clinical databases and the clinical staff at HelloPharmacist — not medical advice — and we don’t sell or endorse products. Our editorial policy
Eyebright 430 mg is a dietary supplement by Bronson Laboratories with 1 active ingredient. Its ingredients are commonly taken for eye irritation and redness, conjunctivitis (pink eye), eye strain.Based on those ingredients, 86 medications have a known interaction with it, the most serious rated moderate. The ingredients most likely to interact are Eyebright. Use the checker below to test your specific medication, or read the full HelloPharmacist Interaction Report.
Check Your Meds Against Eyebright 430 mg by Bronson Laboratories
Ask about any prescription or over-the-counter medication and we check it for interactions with Eyebright 430 mg by Bronson Laboratories — and tell you which ingredient is responsible.
AI summaries are generated from our interaction database for education only — always confirm with your pharmacist. How we use AI
Ask the Pharmacist
A licensed pharmacist will answer your question by email — free, usually within 24 hours.
Got it — thank you!
A licensed pharmacist will answer within 24 hours. Keep an eye on your email (worth checking spam, just in case).
HelloPharmacist Scorecard of Eyebright 430 mg by Bronson Laboratories
Our pharmacy team’s full take, with four database checks built into the cards below — a summary of what is known, not a grade of the product itself.
What’s inside
Full disclosure
This product contains one active ingredient: eyebright, at 430 mg per capsule. Eyebright is an herb traditionally used to support eye and respiratory health, though modern evidence for most of those uses is insufficient.
The capsule itself is made from gelatin and filled with inactive ingredients — dicalcium phosphate, microcrystalline cellulose, magnesium stearate, and silica — which serve as binders and anti-caking agents.
Does it work?
Not established
The evidence we hold does not establish that eyebright is effective for hay fever, cancer, common cold, cough, pharyngitis, or rhinosinusitis — all six conditions listed carry a rating of insufficient reliable evidence to rate. This doesn't mean it doesn't work; it means the data we have isn't strong enough to say either way.
If you're considering it for a specific condition, ask your pharmacist what the current clinical picture looks like.
How safe is it?
Well-documented data
Orally, eyebright is likely safe in small amounts as a tea. In the amounts and form in this capsule, side effects have been reported: confusion and headache are the most common, and some people report nausea, constipation, cough, shortness of breath, or nasal congestion.
Do not use homemade or non-sterile eyebright solutions directly in the eye — that's risky. Safety data in pregnancy advises against use; while breastfeeding, there isn't enough information to know whether it's safe, so talk with your doctor or pharmacist for personalized guidance.
Meds to double-check
Moderate interaction found
If you take any antidiabetes medication — insulin, metformin, sulfonylureas, or any other drug that lowers blood sugar — check your specific medications with the tool on this page before taking Eyebright. Altogether, these interactions span 86 individual medications.
Talk to your doctor or pharmacist to make sure combining them is safe for you.
The bottom line
Scorecard at a glanceFully disclosed formula with no established evidence rating for its marketed use. Moderate medication interactions have been identified, and safety information is well characterized.
Eyebright is an herbal supplement with limited evidence for the conditions it's traditionally used for. Its main interaction risk is with diabetes medications, which could theoretically increase the chance of low blood sugar.
If you take any antidiabetes drug, or if you're pregnant or breastfeeding, check with your doctor or pharmacist before starting this product.
Educational only — not medical advice; always confirm with your pharmacist. Our editorial policy · How we use AI
Assessment coverage: 1 of 1 active ingredient matched to our full ingredient reviews (monographs). Based on the product label dated Sep 25, 2013.
This Scorecard evaluates available label information, ingredient evidence, and known medication-safety considerations. It does not independently verify product identity, purity, potency, contamination, or manufacturing quality. How these ratings are computed
General information
Key facts about Eyebright 430 mg, straight from the product label.
| Brand | Bronson Laboratories |
|---|---|
| Barcode (UPC) | 716563426019 |
| Net contents | 100 Capsule(s) |
| Market status | On market |
| Date entered into DSLD | Sep 25, 2013 |
| DSLD ID | 25295 |
| Product type | Botanical |
| Supplement form | Capsule |
| Dietary claims / uses | All Other, Structure/Function |
| Intended target group(s) | Adult (18 - 50 Years) |
Everything in this section is reproduced from the manufacturer’s own product label — it’s the label speaking, not HelloPharmacist. We show it so you can see exactly what the maker states; we don’t verify or endorse those statements.
Supplement Facts
The label details for Eyebright 430 mg by Bronson Laboratories, sourced from the NIH Dietary Supplement Label Database.
Supplement Facts
| Ingredient | Amount | % DV |
|---|---|---|
| Eyebright | 430 mg | -- |
Other ingredients: Gelatin, Dicalcium Phosphate, Microcrystalline Cellulose, Magnesium Stearate, Silica
Tap any ingredient to jump to its full detail below.
These statements are the manufacturer’s wording, reproduced from the product label — the label is saying it, not HelloPharmacist. We don’t verify or endorse them.
FDA Statement of Identity
Dietary Supplement
General Statements
Herb traditionally used as an eye tonic
EYE HEALTH EST 1960
Made in USA
General
426 REF 0512
Suggested/Recommended/Usage/Directions
Directions: As a dietary supplement for adults, 1 capsule two times daily, or as directed by a health professional.
Precautions
WARNING: If you are pregnant, nursing, have a medical condition, taking any medications or planning any medical procedure, consult your doctor before use.
Keep out of reach of children.
Discontinue use and consult your doctor if any adverse reactions occur.
Storage
Store at room temperature. Protect from light.
FDA Disclaimer Statement
These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure or prevent any disease.
Brand IP Statement(s)
Discover the Bronson Difference(TM)
Is this label outdated? Report a formula or label change and our pharmacy team will review it.
Eyebright 430 mg by Bronson Laboratories label
The label scan from the NIH Dietary Supplement Label Database. Tap to enlarge.
Label images are published by the NIH Dietary Supplement Label Database for the version of this product on file. Always read your actual product label.
View the full label (PDF)The Ingredients in Eyebright 430 mg by Bronson Laboratories
This is the 1 active ingredient this product is made of. Select it to open its full monograph.
Serving size1 Capsule(s) Dosage formCapsule Amounts shown are per serving.
Eyebright
Interacts with86 drugs
Eyebright is a traditional herb long used for minor eye irritation, redness, and allergy symptoms, but high-quality human studies are very limited. Th...
Eyebright monograph & interactionsOther (inactive) ingredients: Gelatin, Dicalcium Phosphate, Microcrystalline Cellulose, Magnesium Stearate, Silica. These complete the product’s ingredient list but are not active constituents.
Eyebright 430 mg by Bronson Laboratories Drug Interactions
HelloPharmacist Interaction Report
Eyebright 430 mg by Bronson Laboratories contains one ingredient — eyebright — that interacts with medications.
The main concern is with antidiabetes drugs (insulin, metformin, sulfonylureas, and others used to lower blood sugar). Animal research suggests eyebright lowers blood glucose levels, so taking it alongside these medications theoretically raises your risk of low blood sugar (hypoglycemia).
Read the full breakdown — every affected drug type, severity by severity
Although this is a moderate-severity interaction, the human evidence is limited. Still, if you take any diabetes medication, check your specific drugs with the tool on this page before starting eyebright, and talk to your doctor or pharmacist about whether it's safe for you to combine them.
Check your own medications below · Editorial policy · How we use AI
Want to check YOUR meds against Eyebright 430 mg?
Ask about interactions with your drugs in plain English — “Can I take it with lisinopril?” — and we find you the answer in seconds, ingredient by ingredient.
Go to the checkerIngredients driving the most interactions
Individual Drug Interactions
The ingredients in Eyebright 430 mg interact with 86 drugs. Click any drug to see the details.
1 of the 1 ingredient in Eyebright 430 mg interact with drugs. Each result below shows which ingredient is responsible. Eyebright
AcarboseGlucobay, Prandase, Precose
How Acarbose interacts with Eyebright 430 mg — through 1 ingredient. Tap an ingredient for the detail:
EyebrightAntidiabetes Drugs Moderate
Interaction Summary
Theoretically, eyebright might increase the risk of hypoglycemia when taken with antidiabetes drugs.
Read the full Eyebright + Acarbose interactionAcetohexamideDymelor
How Acetohexamide interacts with Eyebright 430 mg — through 1 ingredient. Tap an ingredient for the detail:
EyebrightAntidiabetes Drugs Moderate
Interaction Summary
Theoretically, eyebright might increase the risk of hypoglycemia when taken with antidiabetes drugs.
Read the full Eyebright + Acetohexamide interactionAlbiglutideTanzeum
How Albiglutide interacts with Eyebright 430 mg — through 1 ingredient. Tap an ingredient for the detail:
EyebrightAntidiabetes Drugs Moderate
Interaction Summary
Theoretically, eyebright might increase the risk of hypoglycemia when taken with antidiabetes drugs.
Read the full Eyebright + Albiglutide interactionAlogliptinNesina
How Alogliptin interacts with Eyebright 430 mg — through 1 ingredient. Tap an ingredient for the detail:
EyebrightAntidiabetes Drugs Moderate
Interaction Summary
Theoretically, eyebright might increase the risk of hypoglycemia when taken with antidiabetes drugs.
Read the full Eyebright + Alogliptin interactionAlogliptin, MetforminKazano
How Alogliptin, Metformin interacts with Eyebright 430 mg — through 1 ingredient. Tap an ingredient for the detail:
EyebrightAntidiabetes Drugs Moderate
Interaction Summary
Theoretically, eyebright might increase the risk of hypoglycemia when taken with antidiabetes drugs.
Read the full Eyebright + Alogliptin, Metformin interactionAlogliptin, PioglitazoneOseni
How Alogliptin, Pioglitazone interacts with Eyebright 430 mg — through 1 ingredient. Tap an ingredient for the detail:
EyebrightAntidiabetes Drugs Moderate
Interaction Summary
Theoretically, eyebright might increase the risk of hypoglycemia when taken with antidiabetes drugs.
Read the full Eyebright + Alogliptin, Pioglitazone interactionAntidiabetes, Dipeptidyl Peptidase-4 (dpp-iv) InhibitorGlyxambi
How Antidiabetes, Dipeptidyl Peptidase-4 (dpp-iv) Inhibitor interacts with Eyebright 430 mg — through 1 ingredient. Tap an ingredient for the detail:
EyebrightAntidiabetes Drugs Moderate
Interaction Summary
Theoretically, eyebright might increase the risk of hypoglycemia when taken with antidiabetes drugs.
Read the full Eyebright + Antidiabetes, Dipeptidyl Peptidase-4 (dpp-iv) Inhibitor interactionCanagliflozinInvokana
How Canagliflozin interacts with Eyebright 430 mg — through 1 ingredient. Tap an ingredient for the detail:
EyebrightAntidiabetes Drugs Moderate
Interaction Summary
Theoretically, eyebright might increase the risk of hypoglycemia when taken with antidiabetes drugs.
Read the full Eyebright + Canagliflozin interactionCanagliflozin, MetforminInvokamet
How Canagliflozin, Metformin interacts with Eyebright 430 mg — through 1 ingredient. Tap an ingredient for the detail:
EyebrightAntidiabetes Drugs Moderate
Interaction Summary
Theoretically, eyebright might increase the risk of hypoglycemia when taken with antidiabetes drugs.
Read the full Eyebright + Canagliflozin, Metformin interactionCanagliflozin, Metformin HydrochlorideInvokamet XR
How Canagliflozin, Metformin Hydrochloride interacts with Eyebright 430 mg — through 1 ingredient. Tap an ingredient for the detail:
EyebrightAntidiabetes Drugs Moderate
Interaction Summary
Theoretically, eyebright might increase the risk of hypoglycemia when taken with antidiabetes drugs.
Read the full Eyebright + Canagliflozin, Metformin Hydrochloride interactionChlorpropamideChlorpropam, Diabinese
How Chlorpropamide interacts with Eyebright 430 mg — through 1 ingredient. Tap an ingredient for the detail:
EyebrightAntidiabetes Drugs Moderate
Interaction Summary
Theoretically, eyebright might increase the risk of hypoglycemia when taken with antidiabetes drugs.
Read the full Eyebright + Chlorpropamide interactionDapagliflozinFarxiga
How Dapagliflozin interacts with Eyebright 430 mg — through 1 ingredient. Tap an ingredient for the detail:
EyebrightAntidiabetes Drugs Moderate
Interaction Summary
Theoretically, eyebright might increase the risk of hypoglycemia when taken with antidiabetes drugs.
Read the full Eyebright + Dapagliflozin interactionDapagliflozin Propanediol, MetforminXigduo XR
How Dapagliflozin Propanediol, Metformin interacts with Eyebright 430 mg — through 1 ingredient. Tap an ingredient for the detail:
EyebrightAntidiabetes Drugs Moderate
Interaction Summary
Theoretically, eyebright might increase the risk of hypoglycemia when taken with antidiabetes drugs.
Read the full Eyebright + Dapagliflozin Propanediol, Metformin interactionDapagliflozin Propanediol, Saxagliptin HydrochlorideQtern
How Dapagliflozin Propanediol, Saxagliptin Hydrochloride interacts with Eyebright 430 mg — through 1 ingredient. Tap an ingredient for the detail:
EyebrightAntidiabetes Drugs Moderate
Interaction Summary
Theoretically, eyebright might increase the risk of hypoglycemia when taken with antidiabetes drugs.
Read the full Eyebright + Dapagliflozin Propanediol, Saxagliptin Hydrochloride interactionDapagliflozin, Metformin Hydrochloride, Saxagliptin HydrochlorideQternmet XR
How Dapagliflozin, Metformin Hydrochloride, Saxagliptin Hydrochloride interacts with Eyebright 430 mg — through 1 ingredient. Tap an ingredient for the detail:
EyebrightAntidiabetes Drugs Moderate
Interaction Summary
Theoretically, eyebright might increase the risk of hypoglycemia when taken with antidiabetes drugs.
Read the full Eyebright + Dapagliflozin, Metformin Hydrochloride, Saxagliptin Hydrochloride interactionDasiglucagon HydrochlorideZegalogue
How Dasiglucagon Hydrochloride interacts with Eyebright 430 mg — through 1 ingredient. Tap an ingredient for the detail:
EyebrightAntidiabetes Drugs Moderate
Interaction Summary
Theoretically, eyebright might increase the risk of hypoglycemia when taken with antidiabetes drugs.
Read the full Eyebright + Dasiglucagon Hydrochloride interactionDulaglutideTrulicity
How Dulaglutide interacts with Eyebright 430 mg — through 1 ingredient. Tap an ingredient for the detail:
EyebrightAntidiabetes Drugs Moderate
Interaction Summary
Theoretically, eyebright might increase the risk of hypoglycemia when taken with antidiabetes drugs.
Read the full Eyebright + Dulaglutide interactionEmpagliflozinJardiance
How Empagliflozin interacts with Eyebright 430 mg — through 1 ingredient. Tap an ingredient for the detail:
EyebrightAntidiabetes Drugs Moderate
Interaction Summary
Theoretically, eyebright might increase the risk of hypoglycemia when taken with antidiabetes drugs.
Read the full Eyebright + Empagliflozin interactionEmpagliflozin, Linagliptin, Metformin HydrochlorideTrijardy XR
How Empagliflozin, Linagliptin, Metformin Hydrochloride interacts with Eyebright 430 mg — through 1 ingredient. Tap an ingredient for the detail:
EyebrightAntidiabetes Drugs Moderate
Interaction Summary
Theoretically, eyebright might increase the risk of hypoglycemia when taken with antidiabetes drugs.
Read the full Eyebright + Empagliflozin, Linagliptin, Metformin Hydrochloride interactionEmpagliflozin, MetforminSynjardy
How Empagliflozin, Metformin interacts with Eyebright 430 mg — through 1 ingredient. Tap an ingredient for the detail:
EyebrightAntidiabetes Drugs Moderate
Interaction Summary
Theoretically, eyebright might increase the risk of hypoglycemia when taken with antidiabetes drugs.
Read the full Eyebright + Empagliflozin, Metformin interactionEmpagliflozin, Metformin HydrochlorideSynjardy XR
How Empagliflozin, Metformin Hydrochloride interacts with Eyebright 430 mg — through 1 ingredient. Tap an ingredient for the detail:
EyebrightAntidiabetes Drugs Moderate
Interaction Summary
Theoretically, eyebright might increase the risk of hypoglycemia when taken with antidiabetes drugs.
Read the full Eyebright + Empagliflozin, Metformin Hydrochloride interactionErtugliflozinSteglatro
How Ertugliflozin interacts with Eyebright 430 mg — through 1 ingredient. Tap an ingredient for the detail:
EyebrightAntidiabetes Drugs Moderate
Interaction Summary
Theoretically, eyebright might increase the risk of hypoglycemia when taken with antidiabetes drugs.
Read the full Eyebright + Ertugliflozin interactionErtugliflozin, Metformin HydrochlorideSegluromet
How Ertugliflozin, Metformin Hydrochloride interacts with Eyebright 430 mg — through 1 ingredient. Tap an ingredient for the detail:
EyebrightAntidiabetes Drugs Moderate
Interaction Summary
Theoretically, eyebright might increase the risk of hypoglycemia when taken with antidiabetes drugs.
Read the full Eyebright + Ertugliflozin, Metformin Hydrochloride interactionExenatideBydureon, Byetta
How Exenatide interacts with Eyebright 430 mg — through 1 ingredient. Tap an ingredient for the detail:
EyebrightAntidiabetes Drugs Moderate
Interaction Summary
Theoretically, eyebright might increase the risk of hypoglycemia when taken with antidiabetes drugs.
Read the full Eyebright + Exenatide interactionExenatide SyntheticBydureon BCISE
How Exenatide Synthetic interacts with Eyebright 430 mg — through 1 ingredient. Tap an ingredient for the detail:
EyebrightAntidiabetes Drugs Moderate
Interaction Summary
Theoretically, eyebright might increase the risk of hypoglycemia when taken with antidiabetes drugs.
Read the full Eyebright + Exenatide Synthetic interactionGliclazideDiamicron
How Gliclazide interacts with Eyebright 430 mg — through 1 ingredient. Tap an ingredient for the detail:
EyebrightAntidiabetes Drugs Moderate
Interaction Summary
Theoretically, eyebright might increase the risk of hypoglycemia when taken with antidiabetes drugs.
Read the full Eyebright + Gliclazide interactionGlimepirideAmaryl
How Glimepiride interacts with Eyebright 430 mg — through 1 ingredient. Tap an ingredient for the detail:
EyebrightAntidiabetes Drugs Moderate
Interaction Summary
Theoretically, eyebright might increase the risk of hypoglycemia when taken with antidiabetes drugs.
Read the full Eyebright + Glimepiride interactionGlipizideGlucotrol, Glucotrol XL
How Glipizide interacts with Eyebright 430 mg — through 1 ingredient. Tap an ingredient for the detail:
EyebrightAntidiabetes Drugs Moderate
Interaction Summary
Theoretically, eyebright might increase the risk of hypoglycemia when taken with antidiabetes drugs.
Read the full Eyebright + Glipizide interactionGlipizide, MetforminMetaglip
How Glipizide, Metformin interacts with Eyebright 430 mg — through 1 ingredient. Tap an ingredient for the detail:
EyebrightAntidiabetes Drugs Moderate
Interaction Summary
Theoretically, eyebright might increase the risk of hypoglycemia when taken with antidiabetes drugs.
Read the full Eyebright + Glipizide, Metformin interactionGlucagonBaqsimi, Glucagon
How Glucagon interacts with Eyebright 430 mg — through 1 ingredient. Tap an ingredient for the detail:
EyebrightAntidiabetes Drugs Moderate
Interaction Summary
Theoretically, eyebright might increase the risk of hypoglycemia when taken with antidiabetes drugs.
Read the full Eyebright + Glucagon interactionEach ingredient & the kinds of drugs it affects
For each ingredient in Eyebright 430 mg with known interactions, here are the types of medications it can affect. Open any type for the detail — or search your exact drug in the checker above.
Eyebright
Antidiabetes Drugs
Theoretically, eyebright might increase the risk of hypoglycemia when taken with antidiabetes drugs.
Animal research suggests that eyebright lowers blood glucose levels.
Brand information
Manufacturer and brand details for Eyebright 430 mg, from the product label.
Bronson Laboratories
- Name
- Bronson Laboratories
- City
- Lindon
- State
- UT
- ZipCode
- 84042
Eyebright 430 mg by Bronson Laboratories: Common Questions
Does Eyebright 430 mg by Bronson Laboratories interact with any medications?
How can one product interact with so many drugs?
Where does this information come from?
What is eyebright used for?
What side effects might I experience?
Can I use eyebright if I have diabetes and take blood sugar medication?
Is it safe to use while pregnant or breastfeeding?
Can I put this directly in my eyes?
Written and reviewed by the HelloPharmacist editorial staff. Our editorial policy
Not sure if Eyebright 430 mg is safe with your meds?
Our pharmacists answer your medication & supplement questions — free.
Label information is sourced from the NIH Dietary Supplement Label Database and reflects the product version on file; always read your actual product label. This page is for education only and is not a substitute for professional medical advice. Confirm with your pharmacist or doctor before combining supplements and medications.
The Full Monographs Behind Eyebright 430 mg’s Ingredients
Every ingredient we hold a full HelloPharmacist monograph for — uses, evidence, safety, and the complete interaction list.
Sources & How We Checked
Eyebright 430 mg's label data comes from the NIH Dietary Supplement Label Database; the ingredient interaction data is from the Natural Medicines database, reviewed by our pharmacists.
- NIH Dietary Supplement Label Database (DSLD) — The official product label on file for this supplement.
- Natural Medicines (Therapeutic Research Center) — Evidence-graded clinical reference behind the ingredient interaction data.
Content is written and reviewed by licensed HelloPharmacist pharmacists. See our data sources and editorial standards for how this information is built and checked.
The 4 references behind this product’s interaction data
Every citation that drives the interaction findings for this product’s ingredients, from the evidence-graded Natural Medicines (TRC Healthcare) database. Open an ingredient to browse its citations — links open the study on PubMed or the publisher’s site.
Eyebright 4 references
- Newall CA, Anderson LA, Philpson JD. Herbal Medicine: A Guide for Healthcare Professionals. London, UK: The Pharmaceutical Press, 1996.
- Wichtl MW. Herbal Drugs and Phytopharmaceuticals. Ed. N.M. Bisset. Stuttgart: Medpharm GmbH Scientific Publishers, 1994.
- Leung AY, Foster S. Encyclopedia of Common Natural Ingredients Used in Food, Drugs and Cosmetics. 2nd ed. New York, NY: John Wiley & Sons, 1996.
- Porchezhian, E., Ansari, S. H., and Shreedharan, N. K. Antihyperglycemic activity of Euphrasia officinale leaves. Fitoterapia 2000;71(5):522-526. PubMed
Parts of this content are provided by the Therapeutic Research Center, LLC.
DISCLAIMER: Currently this does not check for drug-drug interactions. This is not an all-inclusive comprehensive list of potential interactions and is for informational purposes only. Not all interactions are known or well-reported in the scientific literature, and new interactions are continually being reported. Input is needed from a qualified healthcare provider including a pharmacist before starting any therapy. Application of clinical judgment is necessary.
© 2021 Therapeutic Research Center, LLC